In somatotropinomas, the expression levels of SSTR5 were positively correlated with SSTR2 (r = 0.49, Spearman FDR adjusted P < 0.0001) and SSTR3 (r = 0.28, P = 0.03). The gene discussed is SSTR5; the disease is growth hormone-producing pituitary gland neoplasm.